RecruitingNCT06387654

Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases

Constitution of a Collection of Biological Samples With the Aim of Carrying Out Clinico-biological and Physiopathological Investigations of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases

Sponsor

University Hospital, Toulouse

Enrollment

800 participants

Start Date

May 6, 2024

Study Type

OBSERVATIONAL

Conditions

Skin Diseases Autoimmune Bullous Dermatosis Dysimmune Dermatological Diseases Auto-inflammatory Dermatological Diseases

Summary

The aim of this project is to start a biological and clinical collection of patients presenting autoimmune, dysimmune or auto-inflammatory dermatological diseases. This collection will provide appropriate biological samples to identify new biomarkers and to be accessible to the medical, scientific and industrial communities for the identification of new therapeutic strategies.

Eligibility

Min Age: 6 YearsMax Age: 99 Years

Inclusion Criteria9

Skin damage of documented or probable autoimmune, dysimmune or autoinflammatory origin.
The patients included may be adults or children, and will be:
Patients with autoimmune bullous dermatoses (pemphigus, pemphigoid and others),
Patients with systemic autoimmune diseases associated with skin damage (lupus, scleroderma, dermatomyositis for example),
Patients with cutaneous lupus
Patients with dysimmune skin diseases (psoriasis, eczema)
Patients with immuno-induced dermatological disorders or drug dermatitis
Patients receiving, or likely to receive, new, innovative therapies (new molecule on the market, checkpoint inhibitors, gene therapy, cell therapy, etc.).
Patients with dermatological damage whose autoimmune, dysimmune or auto-inflammatory origin is suspected